HEATHER SHAH

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family VERNON, CT NPI 1598523326

General Payments — all program years on this page

$627.65

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $609.11 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $609.1120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $18.541
2024 $609.1120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078875110 Actelion Pharmaceuticals US, Inc. $28.34 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078875154 Actelion Pharmaceuticals US, Inc. $40.03 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101470465 E.R. Squibb & Sons, L.L.C. $21.82 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104521120 AstraZeneca Pharmaceuticals LP $124.17 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104609436 AstraZeneca Pharmaceuticals LP $19.21 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104652277 AstraZeneca Pharmaceuticals LP $13.80 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105738515 AstraZeneca Pharmaceuticals LP $26.06 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105881368 AstraZeneca Pharmaceuticals LP $22.24 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114370754 Regeneron Healthcare Solutions, Inc. $21.57 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114370756 Regeneron Healthcare Solutions, Inc. $21.71 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115870617 GlaxoSmithKline, LLC. $20.61 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116279402 GlaxoSmithKline, LLC. $31.05 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116437791 GlaxoSmithKline, LLC. $32.81 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118074082 Boehringer Ingelheim Pharmaceuticals, Inc. $19.18 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118299424 Baxter Healthcare $34.32 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118299428 Baxter Healthcare $27.30 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137822620 Takeda Pharmaceuticals U.S.A., Inc. $34.94 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137822622 Takeda Pharmaceuticals U.S.A., Inc. $21.65 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137822624 Takeda Pharmaceuticals U.S.A., Inc. $33.92 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139994515 GENZYME CORPORATION $14.38 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.